SNNUF
Smith & Nephew plc OTC$15.55
Mkt Cap $13.3B
52w Low $14.15
32.2% of range
52w High $18.50
50d MA $16.45
200d MA $16.62
P/E (TTM)
21.0x
EV/EBITDA
10.6x
P/B
2.5x
Debt/Equity
0.6x
ROE
11.6%
P/FCF
16.4x
RSI (14)
—
ATR (14)
—
Beta
0.74
50d MA
$16.45
200d MA
$16.62
Avg Volume
583
About
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction pro…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.58 | 0.59 | +2.1% | 18.40 | +0.0% | +0.0% | -2.6% | -2.6% | -2.6% | -2.6% | — |
| Aug 5, 2025 | AMC | 0.43 | 0.33 | -22.4% | 16.80 | +0.0% | +0.0% | +0.0% | +5.2% | +5.2% | +5.2% | — |
| Apr 30, 2025 | AMC | 0.46 | 0.22 | -52.6% | 14.00 | +0.0% | +0.0% | +0.0% | +1.2% | +1.2% | +1.2% | — |
| Oct 31, 2024 | AMC | 0.39 | 0.25 | -37.5% | 14.33 | +0.0% | +0.0% | +0.0% | -12.6% | -19.8% | -19.8% | — |
| May 1, 2024 | AMC | 0.48 | 0.11 | -78.3% | 12.33 | +0.0% | +0.0% | +0.6% | +0.6% | -1.2% | -0.2% | — |
| Nov 2, 2023 | AMC | 0.37 | 0.20 | -44.4% | 11.86 | +5.1% | +5.1% | +5.1% | +5.1% | +0.0% | +5.9% | — |
| Apr 26, 2023 | AMC | 0.36 | 0.05 | -85.1% | 16.06 | +0.7% | +0.7% | +0.9% | +2.6% | +2.6% | +2.6% | — |
| Nov 3, 2022 | AMC | 0.38 | 0.19 | -49.8% | 11.35 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +5.6% | — |
| Apr 28, 2022 | AMC | 0.43 | 0.36 | -17.1% | 15.63 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jul 29, 2021 | AMC | 0.39 | 0.23 | -41.2% | 20.62 | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3 | Bernstein | Maintains | Outperform → Outperform | — | $11.98 | $11.71 | -2.3% | -2.3% | -2.3% | -2.3% | -1.8% | -1.8% |
| Mar 3 | Redburn Partners | Upgrade | Sell → Neutral | — | $17.35 | $17.10 | -1.4% | -1.4% | -1.4% | -1.4% | -1.4% | -11.0% |
| Apr 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.58 | $21.55 | +4.7% | +4.5% | +4.5% | +4.5% | +4.5% | +8.2% |
| Dec 17 | Bernstein | Upgrade | Market Perform → Outperform | — | $20.23 | $20.95 | +3.6% | +3.6% | +3.6% | +1.5% | +1.5% | +1.5% |
| Oct 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.84 | $17.65 | -6.3% | -6.3% | -6.3% | -6.3% | -6.3% | -1.9% |
| May 6 | CFRA | Maintains | Hold → Hold | — | $19.38 | $19.70 | +1.7% | +1.7% | +1.7% | +1.7% | +1.7% | +1.7% |
| Feb 20 | CFRA | Maintains | Hold → Hold | — | $24.30 | $25.35 | +4.3% | +4.9% | +1.6% | +2.2% | -2.3% | -2.3% |
| Apr 24 | Canaccord Genuity | Maintains | Buy → Buy | — | $19.60 | $19.60 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Aug 7 | UBS | Downgrade | Buy → Neutral | — | $17.55 | $17.55 | +0.0% | +0.0% | +0.0% | +0.0% | -0.9% | -0.9% |
| May 3 | Deutsche Bank | Downgrade | Hold → Sell | — | $18.92 | $18.92 | +0.0% | +0.0% | -8.6% | -8.6% | -8.6% | -8.6% |
Data updated apr 28, 2026 9:25pm
· Source: massive.com